Phytochemicals in the Prevention and Treatment of SARS-CoV-2—Clinical Evidence

Phytochemicals in the Prevention and Treatment of SARS-CoV-2—Clinical Evidence

The first case of SARS-CoV-2 infection was reported in December 2019. Due to the rapid spread of the disease and the lack of adequate therapy, the use of plants that have a long history in the treatment of viral infections has often been considered. The aim of this paper is to provide a brief review...

Full description

Bibliographic Details
Main Authors:	Katarina Bijelić, Maja Hitl, Nebojša Kladar
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Antibiotics
Subjects:	phytotherapy SARS-CoV-2 quercetin curcumin baicalin glycyrrhizin
Online Access:	https://www.mdpi.com/2079-6382/11/11/1614

Similar Items

Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the <i>In-Silico</i> World
by: Muhammad Fayyaz ur Rehman, et al.
Published: (2021-08-01)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
by: Lukas van de Sand, et al.
Published: (2021-04-01)

Phytochemicals as potential antiviral agents in SARS-CoV-2 therapy: an update
by: Nerilson M. Lima, et al.
Published: (2021-07-01)

Phytotherapy and Dietotherapy of COVID-19—An Online Survey Results from Central Part of Balkan Peninsula
by: Nebojša Kladar, et al.
Published: (2022-09-01)

Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment
by: Jingjing Li, et al.
Published: (2021-10-01)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
by: Ming-Feng He, et al.
Published: (2022-10-01)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
by: Keivan Zandi, et al.
Published: (2021-04-01)

The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial
by: Ikram Din Ujjan, et al.
Published: (2023-01-01)

Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2
by: Amin Gasmi, et al.
Published: (2022-08-01)

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Kandeil, et al.
Published: (2021-06-01)

NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
by: Jean Gérain, et al.
Published: (2023-06-01)

Photodynamic Action of Curcumin and Methylene Blue against Bacteria and SARS-CoV-2—A Review
by: Siu Kan Law, et al.
Published: (2023-12-01)

Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 Mpro inhibitor
by: Abd. Kakhar Umar, et al.
Published: (2023-03-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review
by: Alok Raghav, et al.
Published: (2022-12-01)

COVID-19 – Apiphytotherapeutic opportunities for prevention and treatment
by: Cristina MUNTEANU
Published: (2020-12-01)

Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity
by: Boyu Pan, et al.
Published: (2023-01-01)

Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
by: Biswanath Dinda, et al.
Published: (2024-04-01)

Natural Phytochemicals as SIRT Activators—Focus on Potential Biochemical Mechanisms
by: Michał Wiciński, et al.
Published: (2023-08-01)

Phytochemicals Targeting Ferroptosis: Therapeutic Opportunities and Prospects for Treating Breast Cancer
by: Xinyi Zhao, et al.
Published: (2022-11-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
by: Bruno Rizzuti, et al.
Published: (2021-04-01)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
by: Ahmed M. Alluwaimi, et al.
Published: (2020-09-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity
by: Wipawee Nittayananta, et al.
Published: (2024-01-01)

Potential inhibitory properties of structurally modified quercetin/isohamnetin glucosides against SARS-CoV-2 Mpro; molecular docking and dynamics simulation strategies
by: Peter Ifeoluwa Adegbola, et al.
Published: (2023-01-01)

Combined effect of traditional Chinese herbal-based formulations Jing Si herbal tea and Jing Si nasal drop inhibits adhesion and transmission of SARS-CoV2 in diabetic SKH-1 mice
by: Chien-Yi Chiang, et al.
Published: (2022-11-01)

Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes
by: Eli Mireya Sandoval-Gallegos, et al.
Published: (2021-09-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2
by: Kunal Bhattacharya, et al.
Published: (2022-03-01)

Promising Effects of 3-Month Period of Quercetin Phytosome<sup>®</sup> Supplementation in the Prevention of Symptomatic COVID-19 Disease in Healthcare Workers: A Pilot Study
by: Mariangela Rondanelli, et al.
Published: (2022-01-01)

Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)
by: Ruben Manuel Luciano Colunga Biancatelli, et al.
Published: (2020-06-01)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

A Mechanistic Insight into Beneficial Effects of Polyphenols in the Prevention and Treatment of Nephrolithiasis: Evidence from Recent In Vitro Studies
by: Marija Hefer, et al.
Published: (2023-07-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
by: Yanwen Liang, et al.
Published: (2020-05-01)